Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML)
A prospective, single-arm, multicenter, exploratory study to evaluate the efficacy and safety of D-CLAG regimen in the treatment of relapsed or refractory acute myeloid leukemia
Acute Myeloid Leukemia
PROCEDURE: D-CLAG
Complete remission (CR) rate, Complete remission rate after 1 course of D-CLAG regimen, Complete blood count recovery or 1 month after 1 course of D-CLAG regimen
A prospective, single-arm, multicenter, exploratory study to evaluate the efficacy and safety of D-CLAG regimen in the treatment of relapsed or refractory acute myeloid leukemia